News Daily News Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients L.A. McKeown August 24, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016
News Daily News Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests Todd Neale July 28, 2016
News Conference News TVT 2016 Teenage TAVR: Should Practice Forge on While Guidelines Grow Up? Michael O'Riordan June 20, 2016
News Conference News TVT 2016 Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY Michael O'Riordan June 18, 2016
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016
News Daily News Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis Michael O'Riordan June 07, 2016
News Conference News EuroPCR 2012 EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage Caitlin E. Cox May 22, 2012
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012
News Daily News Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy March 06, 2012
News Daily News CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves October 03, 2011